BioCentury | Feb 22, 2018
Finance

Bigger BRAIN Initiative

...Inc. (Tokyo:2802) for a leishmaniasis therapy and $4.1 million to the European Vaccine Initiative , Nagasaki University...
BioCentury | Nov 19, 2016
Strategy

Adding on in fibrosis

...in 2008 in the American Journal of Nephrology by researchers from Miyazaki Hospital and the Nagasaki University...
...Biotech AB, Copenhagen, Denmark Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Miyazaki Hospital, Miyazaki, Japan Nagasaki University...
BioCentury | Jun 17, 2013
Strategy

Externalizing Astellas

...Astellas announced two dengue virus deals: one with Tokyo Institute of Technology and another with Nagasaki University...
...San Mateo, Calif. Medivation Inc. (NASDAQ:MDVN), San Francisco, Calif. MorphoSys AG (Xetra:MOR; Pink:MPSYF), Martinsried, Germany Nagasaki University...
BioCentury | Mar 25, 2013
Company News

Astellas, Nagasaki University, Tokyo Institute of Technology deal

...to treat neglected tropical diseases caused by dengue virus. The Institute of Tropical Medicine at Nagasaki University...
...Astellas are not planning to commercialize any compounds selected under their deal, while Astellas and Nagasaki University...
...caused by protozoan parasites (see BioCentury, Nov. 12, 2012). Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Nagasaki University...
BioCentury | Mar 22, 2013
Company News

Astellas partners with universities for neglected tropical diseases

...to treat neglected tropical diseases caused by dengue virus. The Institute of Tropical Medicine at Nagasaki University...
BioCentury | Jun 2, 2011
Distillery Techniques

Technology: Drug delivery

...Kurosaki, T. et al. Mol. Pharm.; published online May 10, 2011; doi:10.1021/mp2001268 Contact: Takashi Kitahara, Nagasaki University...
Items per page:
1 - 6 of 6
BioCentury | Feb 22, 2018
Finance

Bigger BRAIN Initiative

...Inc. (Tokyo:2802) for a leishmaniasis therapy and $4.1 million to the European Vaccine Initiative , Nagasaki University...
BioCentury | Nov 19, 2016
Strategy

Adding on in fibrosis

...in 2008 in the American Journal of Nephrology by researchers from Miyazaki Hospital and the Nagasaki University...
...Biotech AB, Copenhagen, Denmark Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Miyazaki Hospital, Miyazaki, Japan Nagasaki University...
BioCentury | Jun 17, 2013
Strategy

Externalizing Astellas

...Astellas announced two dengue virus deals: one with Tokyo Institute of Technology and another with Nagasaki University...
...San Mateo, Calif. Medivation Inc. (NASDAQ:MDVN), San Francisco, Calif. MorphoSys AG (Xetra:MOR; Pink:MPSYF), Martinsried, Germany Nagasaki University...
BioCentury | Mar 25, 2013
Company News

Astellas, Nagasaki University, Tokyo Institute of Technology deal

...to treat neglected tropical diseases caused by dengue virus. The Institute of Tropical Medicine at Nagasaki University...
...Astellas are not planning to commercialize any compounds selected under their deal, while Astellas and Nagasaki University...
...caused by protozoan parasites (see BioCentury, Nov. 12, 2012). Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Nagasaki University...
BioCentury | Mar 22, 2013
Company News

Astellas partners with universities for neglected tropical diseases

...to treat neglected tropical diseases caused by dengue virus. The Institute of Tropical Medicine at Nagasaki University...
BioCentury | Jun 2, 2011
Distillery Techniques

Technology: Drug delivery

...Kurosaki, T. et al. Mol. Pharm.; published online May 10, 2011; doi:10.1021/mp2001268 Contact: Takashi Kitahara, Nagasaki University...
Items per page:
1 - 6 of 6